SUZ12 and ovarian carcinoma: SUZ12 expression was found decreased by 12% and 62%, in Ovarian cancer cells with a homozygous and heterozygous deletion in CDK12. Interestingly, this experimental observation adds a directionality in this cause-effect relationship.